Skip to main content
Fig. 2 | Oncology and Therapy

Fig. 2

From: Real-World Treatment Patterns for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Europe and the United States

Fig. 2

Projected treatment regimen use among patients receiving first-line treatment for hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced/metastatic breast cancer in Europe and the United States by category of advanced disease. Data taken from Ipsos Healthcare Global Oncology Monitor©, January 2012–December 2014 (see Table 1 for sample sizes). © Ipsos, all rights reserved

Back to article page